Yasumasa Kanai

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro-Osteitis Disease Activity From a Phase 3 Brodalumab Trial.

Exploratory MRI and Clinical Marker Analysis of Pustulotic Arthro-Osteitis Disease Activity From a Phase 3 Brodalumab Trial.

Journal: The Journal of dermatology

Published: February 26, 2026

Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors.

Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors.

Journal: International journal of retina and vitreous

Published: November 12, 2025

Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study.

Molecular profile of interleukin-17RA blockade by brodalumab in Japanese patients with psoriasis: Results from the ESPRIT study.

Journal: Journal of dermatological science

Published: May 22, 2025

The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.

The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.

Journal: The Journal of dermatology

Published: February 06, 2025

Factors Influencing Treatment Satisfaction and Recognition Gaps Between Physicians and Patients with Systemic Sclerosis.

Factors Influencing Treatment Satisfaction and Recognition Gaps Between Physicians and Patients with Systemic Sclerosis.

Journal: Rheumatology and therapy

Published: September 23, 2024

Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study.

Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study.

Journal: Dermatology and therapy

Published: December 11, 2022

Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.

Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.

Journal: The Journal of dermatology

Published: August 08, 2022

Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study.

Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study.

Journal: JAAD international

Published: June 10, 2022

Treatment with brodalumab is not associated with improved sleep problems in real-life patients with plaque psoriasis: Results of the ProLOGUE study.

Treatment with brodalumab is not associated with improved sleep problems in real-life patients with plaque psoriasis: Results of the ProLOGUE study.

Journal: The Journal of dermatology

Published: June 01, 2022

Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study.

Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study.

Journal: The Journal of dermatology

Published: April 28, 2022

Itching and skin pain in real-life patients with plaque psoriasis: Baseline analysis of the ProLOGUE study.

Itching and skin pain in real-life patients with plaque psoriasis: Baseline analysis of the ProLOGUE study.

Journal: Journal of dermatological science

Published: September 27, 2021

Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study.

Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study.

Journal: Journal of dermatological science

Published: September 22, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026